Thomas Ronan Kennedy

Thomas Ronan Kennedy is a declared insider of cbdMD, Inc. (chief executive), with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 24 August 2021 and the latest from 28 November 2025.

Purchases make up the whole of the open-market record (2 purchases, €22k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant and 1 option exercise.

The latest filing, published on 2 December 2025, reports a share grant in cbdMD, Inc. The last insider purchase was made public on 5 May 2023, 1,262 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.